Oruka Therapeutics (ORKA) Interest Coverage Ratio (QoQ) (2010 - 2020)
Powered by 
Analysis
Oruka Therapeutics (ORKA) Interest Coverage Ratio (QoQ) (2010 - 2020) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.43 Bn | 130.58 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn |
| 3 | Argenx Se | 63.34 Bn | 58.15 Bn | 1.37 Bn |
| 4 | Moderna | 57.98 Bn | 52.85 Bn | 52.00 Mn |
| 5 | Revolution Medicines | 43.98 Bn | 43.98 Bn | - |
| 6 | BeOne Medicines | 39.92 Bn | 34.82 Bn | 1.53 Bn |
| 7 | Alnylam Pharmaceuticals | 35.42 Bn | 32.11 Bn | 992.69 Mn |
| 8 | Royalty Pharma | 28.42 Bn | 27.58 Bn | - |
| 9 | Insmed | 27.36 Bn | 26.20 Bn | 358.27 Mn |
| 10 | Oruka Therapeutics | 5.89 Bn | 4.16 Bn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2020 | -127.86% |
| Jun 30, 2020 | -30.35% |
| Sep 30, 2019 | -148.08% |
| Jun 30, 2019 | 15.33% |
| Sep 30, 2018 | -15.63% |
| Jun 30, 2018 | 22.25% |
| Sep 30, 2017 | 19.50% |
| Jun 30, 2017 | -26.89% |
| Sep 30, 2015 | -107.21% |
| Jun 30, 2015 | 50.46% |
| Sep 30, 2014 | 5.03% |
| Jun 30, 2014 | -0.67% |
| Mar 31, 2014 | 18.90% |
| Jun 30, 2013 | 44.02% |
| Sep 30, 2012 | -62.10% |
| Jun 30, 2012 | 59.28% |
| Mar 31, 2012 | -444.19% |
| Dec 31, 2011 | 144.87% |
| Sep 30, 2011 | -6.87% |
| Jun 30, 2011 | -93.46% |